Get the Stockscreener App
26.86
5.39%
-1.53
Pre-market:
27.00
0.14
+0.52%
Centene Corp stock is traded at $26.86, with a volume of 21.36M.
It is down -5.39% in the last 24 hours and down -50.25% over the past month.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
See More
Previous Close:
$28.39
Open:
$28.16
24h Volume:
21.36M
Relative Volume:
1.93
Market Cap:
$13.37B
Revenue:
$163.07B
Net Income/Loss:
$3.31B
P/E Ratio:
4.3045
EPS:
6.24
Net Cash Flow:
$-490.00M
1W Performance:
-2.08%
1M Performance:
-50.25%
6M Performance:
-58.50%
1Y Performance:
-63.26%
1-Day Range:
$26.82
$28.37
1-Week Range:
$26.25
$29.51
52-Week Range:
$26.25
$80.59
Centene Corp Stock (CNC) Company Profile
Name
Centene Corp
Sector
Industry
Phone
(314) 725-4477
Address
7700 FORSYTH BLVD., ST LOUIS
Compare CNC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
26.86 | 13.94B | 163.07B | 3.31B | -490.00M | 6.24 |
|
UNH
Unitedhealth Group Inc
|
282.12 | 254.96B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
292.39 | 79.17B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
59.64 | 76.79B | 378.96B | 5.28B | 5.94B | 4.19 |
|
ELV
Elevance Health Inc
|
285.98 | 65.10B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
231.52 | 28.72B | 117.76B | 1.21B | 2.39B | 9.95 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Jul-16-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-10-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-02-25 | Downgrade | UBS | Buy → Neutral |
| Jun-09-25 | Resumed | Morgan Stanley | Overweight |
| Jun-02-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-08-25 | Upgrade | Jefferies | Underperform → Hold |
| Feb-06-25 | Downgrade | Argus | Buy → Hold |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Dec-13-24 | Upgrade | UBS | Neutral → Buy |
| Dec-10-24 | Downgrade | Jefferies | Hold → Underperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Mar-21-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jan-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-05-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-20-23 | Initiated | UBS | Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-23-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-30-22 | Initiated | Argus | Buy |
| Aug-26-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-28-22 | Resumed | Barclays | Overweight |
| Jul-14-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-21-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Resumed | Bernstein | Outperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-07-22 | Resumed | Barclays | Overweight |
| Jan-06-22 | Resumed | JP Morgan | Overweight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Reiterated | BMO Capital Markets | Outperform |
| Dec-13-21 | Reiterated | BofA Securities | Buy |
| Dec-13-21 | Reiterated | Credit Suisse | Neutral |
| Dec-13-21 | Reiterated | Mizuho | Neutral |
| Dec-13-21 | Reiterated | Oppenheimer | Outperform |
| Dec-13-21 | Reiterated | Stephens | Overweight |
| Dec-13-21 | Reiterated | Truist | Buy |
| Dec-13-21 | Reiterated | Wells Fargo | Overweight |
| Dec-13-21 | Reiterated | Wolfe Research | Outperform |
| Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-19-21 | Initiated | Wells Fargo | Overweight |
| May-11-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-10-21 | Initiated | Mizuho | Neutral |
| Jan-21-21 | Resumed | Goldman | Neutral |
| Jan-15-21 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Feb-05-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-03-20 | Resumed | Evercore ISI | Outperform |
| Jan-28-20 | Reiterated | Bernstein | Outperform |
| Jan-06-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| May-10-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Oct-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Jul-18-18 | Resumed | Citigroup | Neutral |
| Dec-18-17 | Reiterated | Jefferies | Buy |
| Sep-13-17 | Reiterated | Leerink Partners | Mkt Perform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-22-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
| Mar-23-17 | Downgrade | Citigroup | Buy → Neutral |
| Feb-08-17 | Reiterated | Barclays | Overweight |
| Feb-07-17 | Resumed | Cantor Fitzgerald | Overweight |
| Jan-04-17 | Initiated | Piper Jaffray | Overweight |
View All
Centene Corp Stock (CNC) Latest News
Bragar Eagel & Squire, P.C. Urges Investors in XPLR Infrastructure, Centene, Biohaven, or Capricor to Inquire About Their Rights in Class Action Lawsuits - GlobeNewswire Inc.
Centene Corp. stock underperforms Monday when compared to competitors - MarketWatch
Superior HealthPlan and Centene Foundation Announce Grand Opening of CHDI Multi-Purpose Community Health Center in Uvalde – Company AnnouncementFT.com - Financial Times
CNC Investors Have Opportunity to Lead Centene Corporation Securities Fraud Lawsuit with the Schall Law Firm - Barchart.com
Centene Corporation (CNC) Cuts Outlook After $1.8B ACA Revenue Hit - Insider Monkey
Tapestry To Rally Around 34%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Cantor Fitzgerald downgrades Centene stock rating to Neutral on HIX uncertainty - Investing.com
Centene Slashes 2025 Guidance and Posts Surprise Loss - Mint
How strong is Centene Corporation company’s balance sheetAchieve exceptional returns with expert guidance - jammulinksnews.com
CNC Investors with Losses Have Opportunity to Lead Centene Corporation Securities Fraud Lawsuit - Barchart.com
CNC INVESTOR ALERT: Centene Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
Centene Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo.co
CNC STOCK REMINDER: BFA Law Reminds Centene Corporation Investors with Losses to Contact the Firm by September 8 Legal Deadline - Newsfile
What institutional investors are buying Centene Corporation stockFree Buy/Sell Signal Notifications - jammulinksnews.com
Why Centene Corporation stock attracts strong analyst attentionReal Time Breakout Tracking - metal.it
Centene reports a rare loss as medical costs surge, and the stock hits a decade low - MSN
Centene Reports Loss, Citing Rising Medical Costs - The Wall Street Journal
Centene: Q2 Earnings Snapshot - CTPost
Earnings call transcript: Centene Q2 2025 results reveal EPS miss, stock rises - Investing.com
Earnings call transcript: Centene Q2 2025 results reveal EPS miss, stock rises By Investing.com - Investing.com South Africa
Centene Corp (CNC) Q2 2025 Earnings Call Highlights: Navigating Challenges and Strategizing for ... - Yahoo Finance
Centene Corp (CNC) Q2 2025 Earnings Call Highlights: Navigating Challenges and Strategizing for Future Profitability - GuruFocus
Decoding Centene Corp (CNC): A Strategic SWOT Insight - GuruFocus
Centene bounces back after surprise quarterly loss sent it plunging in pre-market trading - Sherwood News
Centene (CNC) Shares Drop After Q2 Earnings Miss Expectations - GuruFocus
Centene posts big loss in second quarter amid federal health care cuts - STLtoday.com
Centene raises Wall Street optimism that Medicaid insurers can improve profits - Reuters
Why Centene (CNC) Stock Is Trading Up Today - Yahoo Finance
Centene Flags Surging ABA Costs as Medicaid Pressures Mount - Behavioral Health Business
Centene's Q2 loss: Why health insurers face such big headwinds - Yahoo Finance
Intel, Tesla, Centene, Deckers, Charter: Stocks Making The Biggest Moves Today - MSN
Centene (CNC) Faces Challenges with Q2 2025 Loss and Revenue Headwinds - GuruFocus
Centene Earnings: Rising Medical Costs Constrain 2025 Outlook, but Growth Expected in 2026 - Morningstar
Medical Expenses Erode Centene's Bottom Line In Rare Q2 Earnings Miss - Barchart.com
Centene posts loss but promises profitability gains in 2026, shares rise By Reuters - Investing.com
Medical Expenses Erode Centene's Bottom Line in Rare Q2 Earnings Miss - Yahoo Finance
Centene Shooting for Margin Improvement in 2026, Despite New Regulatory Pressures - Morningstar
Centene Stock Showing Signs of Life After Revenue Beat - Schaeffer's Investment Research
Centene stock plunges after surprise loss, soaring medical costs and weak 2025 outlook - Invezz
Centene Clocks First Quarterly Loss In 13 Years, Stock Volatile (UPDATED) - Yahoo Finance
Centene: Pricing In Complete Obliteration (NYSE:CNC) - Seeking Alpha
Centene outlook, Pinnacle & Synovus, Deckers: Trending Tickers - Yahoo Finance
Centene Lays Out Path to Boost 2026 Profit After ACA Stumbles - Bloomberg
Centene reports $253M loss, stock continues slide - The Business Journals
Centene reports surprise loss as medical costs rise; shares fall 14% - Latest news from Azerbaijan
Centene Reports Unexpected Q2 Loss: But Retail Expects Stock To Close Higher - Stocktwits
Centene posts surprise loss as medical costs surge, shares slump - Reuters
Centene stock hits decade low after insurer reports rare loss on higher medical costs - Yahoo Finance
Intel, Centene and Charter Communications fall; Deckers rises - Investing.com
Centene (CNC) Reports Q2 Loss, Tops Revenue Estimates - Yahoo.co
Centene’s stock roars back as investors cheer the devil they know about guidance - MarketWatch
Centene Corp Stock (CNC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.50%
1.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):